| 标题 |
[求助补充材料]
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial |
| 备注 |
需要补充材料
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI |
10.1016/s0140-6736(22)00466-4
doi
|
| 其它 |
期刊:The Lancet 作者:Marc Ferrante; Remo Panaccione; Filip Baert; Peter Bossuyt; Jean–Frédéric Colombel; et al 出版日期:2022-05-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)